Functional and biologic significance of deacetylase3 inhibition in myeloma

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

Richard A Flavell

Understanding Hemotopoietic Neoplasias using Humanized Mice

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Ruben D Carrasco

Validating the eCyPA/CD147 signaling complex for myeloma therapy

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Kenneth C Anderson

Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

Jetze J Tepe

Characterization of Non-Competitive Proteasome Binding

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Daniel M Sullivan

CRM1 INHIBITORS SENSITIZE MULTIPLE MYELOMA CELLS TO TOPOISOMERASE II AND PROTEASOME INHIBITORS

Multiple myeloma and immunoproliferative diseases

Jens G Lohr

Determining the mutational landscape of circulating multiple myeloma cells

Multiple myeloma and immunoproliferative diseases

Pathology

David L Woodland

Immune Evolution in Cancer

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Wei Gu

HAUSP inhibitors in p53-wild type and p53-mutant tumors

Multiple myeloma and immunoproliferative diseases